| |
Annual Report ::
» 2006-2007
» 2005-2006
» 2004-2005
» 2003-2004
» 2002-2003
» 2001-2002
Quaterly Financial Results ::
» 2009-2010:
- Consolidated Results: Q1 | Q2 | Q3 | Q4
- Stand Alone Results: Q1 | Q2 | Q3 | Q4
» 2008-2009:
- Consolidated Results: Q1 | Q2 | Q3 | Q4
- Stand Alone Results: Q1 | Q2 | Q3 | Q4
» 2007-2008:
- Consolidated Results: Q1 | Q2 | Q3 | Q4
- Stand Alone Results: Q1 | Q2 | Q3 | Q4
» 2006-2007: Q1 | Q2 | Q3 | Q4
» 2005-2006: Q1 | Q2 | Q3 | Q4
» 2004-2005: Q1 | Q2 | Q3 | Q4
» 2003-2004: Q1 | Q2 | Q3 | Q4
» 2002-2003: Q1 | Q2 | Q3 | Q4
Investors Presentation
» Q3, FY 2010
» Heumann Pharma Generics, Germany
» Management Discussion Report - FY05
|
|
| |
|
| |
|
| |
Quarterly
Financial Results » |
| :: 2011-2012 :: |
| :: Consolidated Results |
| Q1 | Q2 | Q3 | Q4 |
| :: Stand Alone Results |
| Q1 | Q2 | Q3 | Q4 |
| |
| :: 2010-2011 :: |
| :: Consolidated Results |
| Q1 | Q2 | Q3 | Q4 |
| :: Stand Alone Results |
| Q1 | Q2 | Q3 | Q4 |
|
|
|
| |
|
|
